Overexpression of FASN, a key enzyme involved in de novo adipogenesis, was observed in breast cancer tissues and was associated with cancer progression, recurrence, poor prognosis, and pathological findings [22, 28, 29, 33]. This evidence concerns the gene FASN and breast cancer.